Request for Covid-19 Impact Assessment of this Report
The United States Cobamamide for Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cobamamide for Injection market, reaching US$ million by the year 2028. As for the Europe Cobamamide for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cobamamide for Injection players cover Haerbin Medisan, North China Pharmaceutical Group, Chongqing Yaoyou Pharmaceutical, and Hainan Star Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cobamamide for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.5mg
1.0mg
1.5mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Store
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Haerbin Medisan
North China Pharmaceutical Group
Chongqing Yaoyou Pharmaceutical
Hainan Star Pharmaceutical
Hebei Zhitong Biopharmaceutical
Jiangsu Jiuxu Pharmaceutical
Jiuquan Dadeli pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cobamamide for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cobamamide for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cobamamide for Injection by Country/Region, 2017, 2022 & 2028
2.2 Cobamamide for Injection Segment by Type
2.2.1 0.5mg
2.2.2 1.0mg
2.2.3 1.5mg
2.3 Cobamamide for Injection Sales by Type
2.3.1 Global Cobamamide for Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Cobamamide for Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cobamamide for Injection Sale Price by Type (2017-2022)
2.4 Cobamamide for Injection Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 Other
2.5 Cobamamide for Injection Sales by Application
2.5.1 Global Cobamamide for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Cobamamide for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cobamamide for Injection Sale Price by Application (2017-2022)
3 Global Cobamamide for Injection by Company
3.1 Global Cobamamide for Injection Breakdown Data by Company
3.1.1 Global Cobamamide for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Cobamamide for Injection Sales Market Share by Company (2020-2022)
3.2 Global Cobamamide for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Cobamamide for Injection Revenue by Company (2020-2022)
3.2.2 Global Cobamamide for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Cobamamide for Injection Sale Price by Company
3.4 Key Manufacturers Cobamamide for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cobamamide for Injection Product Location Distribution
3.4.2 Players Cobamamide for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cobamamide for Injection by Geographic Region
4.1 World Historic Cobamamide for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Cobamamide for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cobamamide for Injection Annual Revenue by Geographic Region
4.2 World Historic Cobamamide for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Cobamamide for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cobamamide for Injection Annual Revenue by Country/Region
4.3 Americas Cobamamide for Injection Sales Growth
4.4 APAC Cobamamide for Injection Sales Growth
4.5 Europe Cobamamide for Injection Sales Growth
4.6 Middle East & Africa Cobamamide for Injection Sales Growth
5 Americas
5.1 Americas Cobamamide for Injection Sales by Country
5.1.1 Americas Cobamamide for Injection Sales by Country (2017-2022)
5.1.2 Americas Cobamamide for Injection Revenue by Country (2017-2022)
5.2 Americas Cobamamide for Injection Sales by Type
5.3 Americas Cobamamide for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cobamamide for Injection Sales by Region
6.1.1 APAC Cobamamide for Injection Sales by Region (2017-2022)
6.1.2 APAC Cobamamide for Injection Revenue by Region (2017-2022)
6.2 APAC Cobamamide for Injection Sales by Type
6.3 APAC Cobamamide for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cobamamide for Injection by Country
7.1.1 Europe Cobamamide for Injection Sales by Country (2017-2022)
7.1.2 Europe Cobamamide for Injection Revenue by Country (2017-2022)
7.2 Europe Cobamamide for Injection Sales by Type
7.3 Europe Cobamamide for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cobamamide for Injection by Country
8.1.1 Middle East & Africa Cobamamide for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cobamamide for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Cobamamide for Injection Sales by Type
8.3 Middle East & Africa Cobamamide for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cobamamide for Injection
10.3 Manufacturing Process Analysis of Cobamamide for Injection
10.4 Industry Chain Structure of Cobamamide for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cobamamide for Injection Distributors
11.3 Cobamamide for Injection Customer
12 World Forecast Review for Cobamamide for Injection by Geographic Region
12.1 Global Cobamamide for Injection Market Size Forecast by Region
12.1.1 Global Cobamamide for Injection Forecast by Region (2023-2028)
12.1.2 Global Cobamamide for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cobamamide for Injection Forecast by Type
12.7 Global Cobamamide for Injection Forecast by Application
13 Key Players Analysis
13.1 Haerbin Medisan
13.1.1 Haerbin Medisan Company Information
13.1.2 Haerbin Medisan Cobamamide for Injection Product Offered
13.1.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Haerbin Medisan Main Business Overview
13.1.5 Haerbin Medisan Latest Developments
13.2 North China Pharmaceutical Group
13.2.1 North China Pharmaceutical Group Company Information
13.2.2 North China Pharmaceutical Group Cobamamide for Injection Product Offered
13.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 North China Pharmaceutical Group Main Business Overview
13.2.5 North China Pharmaceutical Group Latest Developments
13.3 Chongqing Yaoyou Pharmaceutical
13.3.1 Chongqing Yaoyou Pharmaceutical Company Information
13.3.2 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Offered
13.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Chongqing Yaoyou Pharmaceutical Main Business Overview
13.3.5 Chongqing Yaoyou Pharmaceutical Latest Developments
13.4 Hainan Star Pharmaceutical
13.4.1 Hainan Star Pharmaceutical Company Information
13.4.2 Hainan Star Pharmaceutical Cobamamide for Injection Product Offered
13.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hainan Star Pharmaceutical Main Business Overview
13.4.5 Hainan Star Pharmaceutical Latest Developments
13.5 Hebei Zhitong Biopharmaceutical
13.5.1 Hebei Zhitong Biopharmaceutical Company Information
13.5.2 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Offered
13.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hebei Zhitong Biopharmaceutical Main Business Overview
13.5.5 Hebei Zhitong Biopharmaceutical Latest Developments
13.6 Jiangsu Jiuxu Pharmaceutical
13.6.1 Jiangsu Jiuxu Pharmaceutical Company Information
13.6.2 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Offered
13.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Jiangsu Jiuxu Pharmaceutical Main Business Overview
13.6.5 Jiangsu Jiuxu Pharmaceutical Latest Developments
13.7 Jiuquan Dadeli pharmaceutical
13.7.1 Jiuquan Dadeli pharmaceutical Company Information
13.7.2 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Offered
13.7.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Jiuquan Dadeli pharmaceutical Main Business Overview
13.7.5 Jiuquan Dadeli pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Cobamamide for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cobamamide for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.5mg
Table 4. Major Players of 1.0mg
Table 5. Major Players of 1.5mg
Table 6. Global Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 7. Global Cobamamide for Injection Sales Market Share by Type (2017-2022)
Table 8. Global Cobamamide for Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Cobamamide for Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Cobamamide for Injection Sale Price by Type (2017-2022) & (US$/g)
Table 11. Global Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 12. Global Cobamamide for Injection Sales Market Share by Application (2017-2022)
Table 13. Global Cobamamide for Injection Revenue by Application (2017-2022)
Table 14. Global Cobamamide for Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Cobamamide for Injection Sale Price by Application (2017-2022) & (US$/g)
Table 16. Global Cobamamide for Injection Sales by Company (2020-2022) & (Kg)
Table 17. Global Cobamamide for Injection Sales Market Share by Company (2020-2022)
Table 18. Global Cobamamide for Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Cobamamide for Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Cobamamide for Injection Sale Price by Company (2020-2022) & (US$/g)
Table 21. Key Manufacturers Cobamamide for Injection Producing Area Distribution and Sales Area
Table 22. Players Cobamamide for Injection Products Offered
Table 23. Cobamamide for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Cobamamide for Injection Sales by Geographic Region (2017-2022) & (Kg)
Table 27. Global Cobamamide for Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Cobamamide for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Cobamamide for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Cobamamide for Injection Sales by Country/Region (2017-2022) & (Kg)
Table 31. Global Cobamamide for Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Cobamamide for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Cobamamide for Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 35. Americas Cobamamide for Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Cobamamide for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Cobamamide for Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 39. Americas Cobamamide for Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 41. Americas Cobamamide for Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Cobamamide for Injection Sales by Region (2017-2022) & (Kg)
Table 43. APAC Cobamamide for Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Cobamamide for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Cobamamide for Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 47. APAC Cobamamide for Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 49. APAC Cobamamide for Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 51. Europe Cobamamide for Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Cobamamide for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Cobamamide for Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 55. Europe Cobamamide for Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 57. Europe Cobamamide for Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 59. Middle East & Africa Cobamamide for Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Cobamamide for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Cobamamide for Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 63. Middle East & Africa Cobamamide for Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 65. Middle East & Africa Cobamamide for Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Cobamamide for Injection
Table 67. Key Market Challenges & Risks of Cobamamide for Injection
Table 68. Key Industry Trends of Cobamamide for Injection
Table 69. Cobamamide for Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Cobamamide for Injection Distributors List
Table 72. Cobamamide for Injection Customer List
Table 73. Global Cobamamide for Injection Sales Forecast by Region (2023-2028) & (Kg)
Table 74. Global Cobamamide for Injection Sales Market Forecast by Region
Table 75. Global Cobamamide for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Cobamamide for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Cobamamide for Injection Sales Forecast by Country (2023-2028) & (Kg)
Table 78. Americas Cobamamide for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Cobamamide for Injection Sales Forecast by Region (2023-2028) & (Kg)
Table 80. APAC Cobamamide for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Cobamamide for Injection Sales Forecast by Country (2023-2028) & (Kg)
Table 82. Europe Cobamamide for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Cobamamide for Injection Sales Forecast by Country (2023-2028) & (Kg)
Table 84. Middle East & Africa Cobamamide for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Cobamamide for Injection Sales Forecast by Type (2023-2028) & (Kg)
Table 86. Global Cobamamide for Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Cobamamide for Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Cobamamide for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Cobamamide for Injection Sales Forecast by Application (2023-2028) & (Kg)
Table 90. Global Cobamamide for Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Cobamamide for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Cobamamide for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Haerbin Medisan Basic Information, Cobamamide for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Haerbin Medisan Cobamamide for Injection Product Offered
Table 95. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2022)
Table 96. Haerbin Medisan Main Business
Table 97. Haerbin Medisan Latest Developments
Table 98. North China Pharmaceutical Group Basic Information, Cobamamide for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. North China Pharmaceutical Group Cobamamide for Injection Product Offered
Table 100. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2022)
Table 101. North China Pharmaceutical Group Main Business
Table 102. North China Pharmaceutical Group Latest Developments
Table 103. Chongqing Yaoyou Pharmaceutical Basic Information, Cobamamide for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Offered
Table 105. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2022)
Table 106. Chongqing Yaoyou Pharmaceutical Main Business
Table 107. Chongqing Yaoyou Pharmaceutical Latest Developments
Table 108. Hainan Star Pharmaceutical Basic Information, Cobamamide for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Hainan Star Pharmaceutical Cobamamide for Injection Product Offered
Table 110. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2022)
Table 111. Hainan Star Pharmaceutical Main Business
Table 112. Hainan Star Pharmaceutical Latest Developments
Table 113. Hebei Zhitong Biopharmaceutical Basic Information, Cobamamide for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Offered
Table 115. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2022)
Table 116. Hebei Zhitong Biopharmaceutical Main Business
Table 117. Hebei Zhitong Biopharmaceutical Latest Developments
Table 118. Jiangsu Jiuxu Pharmaceutical Basic Information, Cobamamide for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Offered
Table 120. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2022)
Table 121. Jiangsu Jiuxu Pharmaceutical Main Business
Table 122. Jiangsu Jiuxu Pharmaceutical Latest Developments
Table 123. Jiuquan Dadeli pharmaceutical Basic Information, Cobamamide for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Offered
Table 125. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2022)
Table 126. Jiuquan Dadeli pharmaceutical Main Business
Table 127. Jiuquan Dadeli pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Cobamamide for Injection
Figure 2. Cobamamide for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cobamamide for Injection Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Cobamamide for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cobamamide for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.5mg
Figure 10. Product Picture of 1.0mg
Figure 11. Product Picture of 1.5mg
Figure 12. Global Cobamamide for Injection Sales Market Share by Type in 2021
Figure 13. Global Cobamamide for Injection Revenue Market Share by Type (2017-2022)
Figure 14. Cobamamide for Injection Consumed in Hospital
Figure 15. Global Cobamamide for Injection Market: Hospital (2017-2022) & (Kg)
Figure 16. Cobamamide for Injection Consumed in Drug Store
Figure 17. Global Cobamamide for Injection Market: Drug Store (2017-2022) & (Kg)
Figure 18. Cobamamide for Injection Consumed in Other
Figure 19. Global Cobamamide for Injection Market: Other (2017-2022) & (Kg)
Figure 20. Global Cobamamide for Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Cobamamide for Injection Revenue Market Share by Application in 2021
Figure 22. Cobamamide for Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Cobamamide for Injection Revenue Market Share by Company in 2021
Figure 24. Global Cobamamide for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Cobamamide for Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Cobamamide for Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Cobamamide for Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Cobamamide for Injection Sales 2017-2022 (Kg)
Figure 29. Americas Cobamamide for Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Cobamamide for Injection Sales 2017-2022 (Kg)
Figure 31. APAC Cobamamide for Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Cobamamide for Injection Sales 2017-2022 (Kg)
Figure 33. Europe Cobamamide for Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Cobamamide for Injection Sales 2017-2022 (Kg)
Figure 35. Middle East & Africa Cobamamide for Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Cobamamide for Injection Sales Market Share by Country in 2021
Figure 37. Americas Cobamamide for Injection Revenue Market Share by Country in 2021
Figure 38. United States Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Cobamamide for Injection Sales Market Share by Region in 2021
Figure 43. APAC Cobamamide for Injection Revenue Market Share by Regions in 2021
Figure 44. China Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Cobamamide for Injection Sales Market Share by Country in 2021
Figure 51. Europe Cobamamide for Injection Revenue Market Share by Country in 2021
Figure 52. Germany Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Cobamamide for Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Cobamamide for Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Cobamamide for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Cobamamide for Injection in 2021
Figure 65. Manufacturing Process Analysis of Cobamamide for Injection
Figure 66. Industry Chain Structure of Cobamamide for Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...